Non alcoholic steatohepatitis

Non alcoholic steatohepatitis - Factbites
Where results make sense
About us | Why use us? | Reviews | PR | Contact us

Topic: Non alcoholic steatohepatitis

Note: these results are not from the primary (high quality) database.

In the News (Sat 26 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Non-alcoholic steatohepatitis - Wikipedia, the free encyclopedia
		As its name signifies, Non-alcoholic steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) is fatty inflammation of the liver when this is not due to excessive alcohol use.
		Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
	en.wikipedia.org /wiki/Non-alcoholic_steatohepatitis (351 words)

	Obesity and Fatty Liver disease on MedicineNet.com
		Estimates of the number of cases of non alcoholic fatty liver disease among the obese and patients with diabetes mellitus type 2 (DM2) suggest that 90% have fatty liver, 20% have non alcoholic steatohepatitis, and 10% have cirrhosis.
		In non alcoholic steatohepatitis there is accumulation of fat in the liver, but there also is inflammation (hepatitis), destruction (necrosis) of liver cells, and scarring (fibrosis) of the liver.
		The presumptive diagnosis of non alcoholic fatty liver disease or non alcoholic steatohepatitis is made in individuals who are insulin resistant, have mildly elevated liver enzymes in the blood, and have signs of fatty liver on an ultrasound.
	www.medicinenet.com /script/main/art.asp?articlekey=46582&page=2 (965 words)

	Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? -- Day 50 (5): 585 -- Gut
		CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis.
		Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
		Mechanisms of disease: cytokines in alcoholic and non-alcoholic steatohepatitis.
	gut.bmjjournals.com /cgi/content/full/50/5/585 (2897 words)

	What is NAFLD/NASH? (Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis) - Liver Health Information - The American Liver Foundation
		Nonalcoholic steatohepatitis (NASH) is described as inflammation of the liver associated with the accumulation of fat in the liver.
		In NASH, which resembles alcoholic steatohepatitis, the inflammation of the liver is associated with an increase of fat deposits and typically occurs in middle-aged, overweight, and often diabetic patients who do not drink alcohol.
		Alcoholism could also result in inflammation of the liver (alcoholic hepatitis) and/or scarring (alcoholic cirrhosis) and needs to be differentiated from NASH by patient history.
	liverfoundation.org /db-select/articles/CatNonAlcy/1/1/ascend/Validated (1195 words)

	HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis, Owl Genomics
		Non alcoholic steatohepatitis is a progressive disease of the liver of unknown etiology, characterized histologically by fatty acid accumulation, hepatocyte damage and inflammation resembling alcoholic hepatitis.
		HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis, Owl Genomics
		This chip also assess the efficacy of non-alcoholic steatohepatitis treatment by determining progression or regression of NASH in patients before, during, and NASH treatment.
	i-newswire.com /goprint14841.html (495 words)

	Obesity and Fatty Liver disease on MedicineNet.com
		In the late stages of non alcoholic fatty liver disease, the development of cirrhosis can lead to failure of the liver, swelling of the legs (edema), accumulation of fluid in the abdomen (ascites), bleeding from veins in the esophagus (varices), and mental confusion (hepatic encephalopathy).
		Non alcoholic fatty liver disease is currently the most common liver disease in the US and worldwide, affecting estimated 10-24% of the world’s population.
		All of the stages of non alcoholic fatty liver disease are now believed to be due to insulin resistance, a condition closely associated with obesity.
	www.medicinenet.com /script/main/art.asp?articlekey=46582&page=2 (845 words)

	NASH, Primary Sclerosing Cholangitis Literature
		Burke A, Lucey MR 2004 Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.
		Neuschwander-Tetri BA 2001 Fatty liver and nonalcoholic steatohepatitis.
		Feher J, Lengyel G 2003 A new approach to drug therapy in non-alcoholic steatohepatitis (NASH).
	www.psc-literature.org /NASH.htm (5072 words)

	Alcoholism @ Alky.com
		Stereotypes of alcohol abusers and alcohol dependents are often found in fiction and popular culture: for example the "town drunk," or the stereotype of Russians and the Irish as alcoholics.
		Alcoholism is often a controversial subject and the disease hypothesis represents a focus of the debate.
		Alcohol abuse and alcohol dependence sometimes cause death, particularly through liver, pancreatic, or kidney disease, internal bleeding, brain deterioration, alcohol poisoning, and suicide.
	www.alky.com (4376 words)

	British Liver Trust
		The term "non-alcoholic steatohepatitis" (NASH), describes a liver disease which closely resembles alcoholic liver disease but occurs in individuals consuming little or no alcohol.
		As with alcoholic liver disease the initial step in the evolution of NASH is almost certainly the deposition of excess fat within the liver.
		Like non insulin-dependent diabetes mellitus (NIDDM) and coronary heart disease, NASH may be considered a "disease of affluence" and as a result is almost certainly increasing in frequency.
	www.britishlivertrust.org.uk /content/diseases/non-alcoholic_steato_hepatitis.asp (359 words)

	Nonalcoholic Steatohepatitis
		Nonalcoholic steatohepatitis or NASH is a common, often "silent" liver disease.
		Nonalcoholic steatohepatitis (NASH) is fat in the liver, with inflammation and damage.
		NASH occurs in people who drink little or no alcohol and affects 2 to 5 percent of Americans, especially people who are middle-aged and overweight or obese.
	digestive.niddk.nih.gov /ddiseases/pubs/nash (1519 words)

	Alcohol-Induced Liver Disorders: Cirrhosis and Hepatitis
		Alcoholism is not always the cause of steatohepatitis.
		Fatty liver disease, or steatohepatitis, is one of the first signs that alcohol is causing adverse effects.
		Alcohol is a toxin that disrupts the metabolism and, in sufficient quantities, damages internal organs, particularly the central nervous system.
	www.liverdisordersfocus.com /liver-disorders/alcoholic-liver.php (452 words)

	Non-alcoholic steatohepatitis - Overview
		Non-alcoholic steatohepatitis occurs worldwide in both sexes at all ages, though its occurrence across the globe probably varies widely.
		Non-alcoholic fatty liver on its own is very common, particularly in the obese, may or may not be associated with minor abnormalities of liver function tests and does not seem to predispose to more severe liver disease.
		Nonalcoholic fatty liver disease: an agenda for clinical research.
	www.rcpe.ac.uk /education/education/CME/hepatology/nash/nash_2.html (971 words)

	Health Information-Fatty Liver-California Pacific Medical Center
		Steatohepatitis may be associated with alcohol use, but if the liver damage is unrelated to alcohol, the condition is called non-alcoholic steatohepatitis (NASH).
		Current findings show that while fatty liver is usually present during excessive alcohol intake, it probably does not lead to the development of alcoholic hepatitis or cirrhosis.
		Fatty liver can be present in patients with alcoholic hepatitis and cirrhosis or may be an isolated finding.
	www.cpmc.org /advanced/liver/patients/topics/fatty_liver.html (804 words)

	DSpace at Oregon State University: Item 1957/1026
		Non-alcoholic Steatohepatitis (NASH) is an emerging form of liver disease associated with obesity, type II diabetes and dyslipidemia.
		The role of CYP2E1 and CYP4A in the development of non-alcoholic steatohepatitis
		The pathology of this disease is similar to its alcoholic form, however the cause leading from a steatotic liver to NASH has yet to be discovered.
	hdl.handle.net /1957/1026 (256 words)

	Nonalcoholic steatohepatitis: More than just being fat
		In fact, nonalcoholic steatohepatitis (NASH) may frequently be a precursor of cryptogenic cirrhosis (8).
		Nonalcoholic fatty liver disease (NAFLD) is now recognized as a clinicopathological entity that extends beyond uncomplicated steatosis to steatohepatitis (fat plus inflammation, histologically resembling alcoholic hepatitis), steatonecrosis, advanced fibrosis, liver failure and, in some cases, hepatocellular carcinoma (2-7).
		Only a minority of persons with simple steatosis develop steatohepatitis and fibrosis (2,5).
	www.pulsus.com /Gastro/16_05/edie_ed.htm (1776 words)

	gihealth.com - built for patient satisfaction
		They termed this condition non-alcoholic steatohepatitis, commonly referred to as NASH.
		There are two basic categories of fatty liver - that seen in alcoholics and that which occurs in non-drinkers.
		The first stage of alcoholic liver disease is a fatty liver.
	www.gihealth.com /html/education/fattyLiver.html (1182 words)

	NIH Guide: CLINICAL RESEARCH NETWORK IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
		RESEARCH OBJECTIVES Background Non-alcoholic steatohepatitis (NASH), also known as fatty liver hepatitis, is a clinical-pathological condition that only recently has been recognized to be a common and potentially severe form of liver disease.
		This RFA, Clinical Research Network in Non-Alcoholic Steatohepatitis (NASH), is related to the priority areas of chronic disabling conditions and diabetes.
		These features resemble alcoholic liver disease, but this condition occurs in persons who drink little alcohol or none at all.
	grants.nih.gov /grants/guide/rfa-files/RFA-DK-01-025.html (7598 words)

	What is the treatment for fatty liver? - Stomach/Abdomen - DoctorNDTV
		In purely medical terms, the condition which you have is known as Non Alcoholic Steatohepatitis.
		There are reports in the literature that vitamin E 400 i.u once a day helps to reverse non alcoholic staetohepatitis.
		However your LFT and Triglycerides have been elevated and your ultrasound has revealed a fatty liver.
	www.doctorndtv.com /FAQ/detailfaq.asp?id=5493 (306 words)

	Interaction of Steatosis and Non-Alcoholic Steatohepatitis (NASH) in Chronic Hepatitis C
		Hepatic steatosis or superimposed non-alcoholic steatohepatitis (NASH) may affect HCV-related fibrosis and the efficacy of anti-viral therapy.
		Interaction of Steatosis and Non-Alcoholic Steatohepatitis (NASH) in Chronic Hepatitis C
		The objective of this study was to determine the relationship of hepatic steatosis and NASH with chronic hepatitis C (CHC).
	www.hivandhepatitis.com /hep_c/news/052103f.html (359 words)

	ASTP Abstract kli062.htm
		Background: Patients with non-alcoholic steatohepatitis (NASH) can develop progressive liver dysfunction necessitating orthotopic liver transplantation (OLT).
		In two patients, including one with jejunoileal bypass, transition from mild steatosis to severe steatosis and steatohepatitis was observed over one to two years.
		Conclusion: Patients undergoing OLT for end-stage liver disease as a result of NASH may develop recurrent steatosis shortly after transplantation, with possible progression to steatohepatitis and fibrosis.
	www.a-s-t.org /abstracts/kli062.htm (339 words)

	MCM Treatment for NASH
		Non-alcoholic steatohepatitis was first reported in 1980 by Ludwig et al.
		This number is greater than the total estimated US Hepatitis C patient population(1.8%), making non-alcoholic steatohepatitis a serious health problem.
		Since alcohol related liver disease also causes fatty liver, the name NASH is used to distinguish non-alcohol related cases of fatty liver.
	www.sinomedresearch.org /NASH/NASH1.htm (432 words)

	Steatohepatitis (fatty liver) - Patient UK
		Steatohepatitis (fatty liver) - Patient UK PatientPlus articles are written for doctors and so the language can be technical.
		Fatty liver (steatosis) is first histological feature of alcoholic liver disease occurring at some time in most heavy drinkers.
		Splenomegaly ±portal hypertension plus stigmata of chronic liver disease may be seen in patients with cirrhosis.
	www.patient.co.uk /showdoc/40024505 (378 words)

	Dr. Rose's Peripheral Brain--NON-ALCOHOLIC STEATOHEPATITIS
		Definition = liver bx changes c/w alcoholic hepatitis in absence of excessive alochol intake (fatty changes and hepatocyte injury, with or w/o fibrosis; may see cirrhotic changes)
	www.raywhowemd.com /steat.htm (98 words)

	Relative Risks Of Cirrhosis From Non-alcoholic Steatohepatitis
		Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
		Article: "Similarities and Differences in Outcomes of Cirrhosis Due to Nonalcoholic Steatohepatitis and Hepatitis C," Arun J. Sanyal, Colin Banas, Carol Sargeant, Velimer A. Luketic, Richard K. Sterling, Richard T. Stravitz, Mitchell L. Shiffman, Douglas Heuman, Adrian Cotterell, Robert A. Fisher, Melissa J. Contos, and Alan S. Mills, Hepatology; April 2006 (DOI: 10.1002/hep.21103).
		Non-alcoholic steatohepatitis can develop as a consequence of obesity and the metabolic syndrome.
	www.pharma-lexicon.com /medicalnews.php?newsid=40915 (614 words)

	NASH Support - Non-Alcoholic Steatophepatitis - A Liver Disease
		In 1980 a liver disease was identified as Non-Alcoholic Steatohepatitis (NASH.) NASH is a liver disease,
		with the appearance of Alcoholic Steatohepatitis (ASH,) in patients who deny alcohol use.
	www.liver-nash.com (286 words)

	Pioglitazone Improves Fatty Liver
		In animal model with steatohepatitis, metformin treatment improved hepatic steatosis and inflammation.
		The degree of improvement in insulin sensitivity is related to the intensity of exercise.
		In a recent study, Metformin was associated with an improvement in serum aminotransferase activities.
	www.natap.org /2005/ddw/ddw_1.htm (797 words)

	Fluctuating ALT level
		Non-alcoholic steatohepatitis or NASH is a condition in which fat settles in the liver and causes a specific type of inflammation that has due to do with oxidation of the fat.
		You will also need tests for a few other causes of liver disease and you will want to avoid any medications that can cause liver damage while you are sorting things out.
		We see the condition in people who are overweight, who have high cholesterol and triglycerides and who might have diabetes.
	www.medhelp.org /forums/Hepatitis/messages/30403.html (501 words)

	www.rooseveltrock.com - Medical and health information, Free Beauty Tips, Disease information
		Non steatosis liver disease Non-alcoholic fatty liver disease.
		Non smoking and bladder cancer Public institution dedicated to reducing the burden of cancer for all U. Citizens and people around the world.
		Patients who have chronic liver disease that is due to alcohol effect that smoking cigarettes has on the liver damage caused by a common chronic liver disease, hepatitis C. Information on many different cancers includes symptoms, cancer detection and prevention, and treatment options.
	www.rooseveltrock.com /content/chapter62.html (15726 words)

	Effect of Sinai san decoction on the development of non-alcoholic steatohepatitis in rats. - Chinese Medicine and Herbs from Medline
		To explore the effect of Sinai san decoction on the development of non-alcoholic steatohepatitis induced by CCL4 combined with a fat-rich diet in rats.
		Effect of Sinai san decoction on the development of non-alcoholic steatohepatitis in rats.
		Sinai san decoction may ameliorate the hepatic inflammation of rats with steatohepatitis induced by small dosage of CCL4 combined with a fat-rich diet, but does not prevent the development of hepatocyte steatosis.
	www.famouschinese.com /viewmedline?id=15761983&cdate=03/11/2005 (349 words)

Try your search on: Qwika (all wikis)

Topic: Non alcoholic steatohepatitis

Ads by Google

Related Topics

In the News (Sat 26 Dec 09)